Skip to content

Cingulate Inc.: 10-Q filed 2024-11-07

What Cingulate Inc. reported in its quarterly report filed 2024-11-07 (fiscal Q3 2024): 34 published measures, 100 facts as tagged in accession 0001493152-24-043916.

This filing

Form
10-Q (quarterly report)
Filed
2024-11-07
Fiscal period
fiscal Q3 2024
Accession
0001493152-24-043916 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cingulate Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-09-3013,580,104USD
At 2023-12-313,491,436USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-09-301,542,541USD
At 2023-12-3110,360,865USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-09-3012,037,563USD
At 2024-06-303,083,772USD
At 2024-03-313,216,119USD
At 2023-12-31-6,869,429USD
At 2023-09-30-96,334USD
At 2023-06-30-6,098,521USD
At 2023-03-3181,614USD
At 2022-12-313,882,022USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-09-3010,040,149USD
At 2023-12-3152,416USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-3,231,604USD92
2024-01-01 to 2024-09-30-9,413,758USD274
2024-04-01 to 2024-06-30-3,209,677USD91
2024-01-01 to 2024-03-31-2,972,477USD91
2023-07-01 to 2023-09-30-5,979,054USD92
2023-01-01 to 2023-09-30-16,600,250USD273
2023-04-01 to 2023-06-30-6,616,309USD91
2023-01-01 to 2023-03-31-4,004,887USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-14,371,857USD274
2023-01-01 to 2023-09-30-12,472,172USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2024-01-01 to 2024-09-3013,338USD274
2023-01-01 to 2023-09-3037,136USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-09-3024,372,928USD274
2023-01-01 to 2023-09-309,139,345USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-13,338USD274
2023-01-01 to 2023-09-30-37,136USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-09-30-102,357,201USD
At 2023-12-31-92,943,443USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-07-01 to 2024-09-301,766,362shares92
2024-01-01 to 2024-09-30936,118shares274
2023-07-01 to 2023-09-3082,361shares92
2023-01-01 to 2023-09-3059,533shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-07-01 to 2024-09-301,766,362shares92
2024-01-01 to 2024-09-30936,118shares274
2023-07-01 to 2023-09-3082,361shares92
2023-01-01 to 2023-09-3059,533shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-1.83USD/shares92
2024-01-01 to 2024-09-30-10.06USD/shares274
2023-07-01 to 2023-09-30-72.6USD/shares92
2023-01-01 to 2023-09-30-278.84USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-1.83USD/shares92
2024-01-01 to 2024-09-30-10.06USD/shares274
2023-07-01 to 2023-09-30-72.6USD/shares92
2023-01-01 to 2023-09-30-278.84USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-09-302,066,515USD
At 2023-12-312,545,965USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-01-01 to 2024-09-30935,135USD274
2023-01-01 to 2023-09-30658,106USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-3,282,087USD92
2024-01-01 to 2024-09-30-9,436,484USD274
2023-07-01 to 2023-09-30-5,749,674USD92
2023-01-01 to 2023-09-30-15,962,038USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-09-3011,343,611USD
At 2023-12-31578,594USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-09-301,542,541USD
At 2023-12-3110,225,766USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-09-30906,215USD
At 2023-12-315,199,106USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-07-01 to 2024-09-301,428,504USD92
2024-01-01 to 2024-09-305,116,582USD274
2023-07-01 to 2023-09-303,923,852USD92
2023-01-01 to 2023-09-3010,508,395USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-09-303,044,165shares
At 2023-12-3197,293shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-09-30114,394,459USD
At 2023-12-3186,074,004USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-09-30169,978USD
At 2023-12-31366,877USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2024-09-305,202,286USD
At 2023-12-315,188,948USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2024-09-303,135,771USD
At 2023-12-312,642,983USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2024-09-30402,152USD
At 2023-12-311,651,518USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2024-09-301,301,215USD
At 2023-12-31511,556USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-3,231,604USD92
2024-01-01 to 2024-09-30-9,413,758USD274
2023-07-01 to 2023-09-30-5,979,054USD92
2023-01-01 to 2023-09-30-16,600,250USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-07-01 to 2024-09-301,853,583USD92
2024-01-01 to 2024-09-304,319,902USD274
2023-07-01 to 2023-09-301,825,822USD92
2023-01-01 to 2023-09-305,453,643USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2024-07-01 to 2024-09-30165,406USD92
2024-01-01 to 2024-09-30492,788USD274
2023-07-01 to 2023-09-30154,663USD92
2023-01-01 to 2023-09-30410,593USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-07-01 to 2024-09-3050,483USD92
2024-01-01 to 2024-09-3022,726USD274
2023-07-01 to 2023-09-30-229,380USD92
2023-01-01 to 2023-09-30-638,212USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-01-01 to 2024-09-306,160USD274
2023-01-01 to 2023-09-3010,266USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-01-01 to 2024-09-3024,385,615USD274
2023-01-01 to 2023-09-306,151,288USD273

Inspect the source

Entity
Cingulate Inc. / CIK 0001862150
Captured
2026-09-21T17:31:56.019Z
SEC response SHA-256
59c430e5770a7e8cc03543e1d4bfa9a260f4983bc9e7b0469dac795e6803ef32

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001862150.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))